Polyp of Colon Clinical Trial
Official title:
Prospective, Multicenter Study for the Evaluation of Safety and Performance of the Interscope EndoRotor Endoscopic Mucosal Resection System for the Removal of Alimentary Tract Mucosa in the Colon
NCT number | NCT04203667 |
Other study ID # | CLIN-0001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | April 18, 2018 |
Est. completion date | April 5, 2020 |
Verified date | April 2022 |
Source | Interscope, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The EndoRotor® is intended for use (USA labeling) in endoscopic procedures by a trained gastroenterologist to resect and remove tissue, not intended for biopsy, of the gastrointestinal (GI) system including post-endoscopic mucosal resection (EMR) tissue persistence with a scarred base and residual tissue from the peripheral margins following EMR. In this trial investigators will conduct a post-market, prospective, non-randomized, multi-center study for the treatment of subjects with the need for resection of recurrent flat or sessile colorectal lesions where EndoRotor is the primary resection modality of persistent adenoma with a scarred base.
Status | Completed |
Enrollment | 66 |
Est. completion date | April 5, 2020 |
Est. primary completion date | April 5, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility | Inclusion Criteria: 1. Subjects aged =18 to =85 years. 2. At least one recurrent flat or sessile colorectal lesion measuring up to 6 cm in diameter and/or length. 3. Presence of recurrent flat or sessile lesion where the EndoRotor may be used to resect recurrent neoplasia. 4. Favorable anatomy that allows the investigator to access the lesion. 5. Subject is able and willing to comply with site standard medical follow-up, including the 90-day follow-up visit. 6. Subject has been informed of the nature of the study, agrees to participate and has signed the consent form. Exclusion Criteria: 1. Inability to give informed consent. 2. Subject age is <18 years of age or >85 years of age. 3. Presence of a lesion that represents cancer or has a high chance of harboring submucosal invasive cancer. 4. Presence of synchronous lesions intended for resection that would require use of a concomitant resection modality 5. Medical reasons the procedure cannot be performed (i.e. labile blood pressure, anticoagulation laboratory levels that are too high and risk excessive bleeding, systemic infection, etc.) 6. Active antiplatelet therapy (Plavix , 325mg aspirin therapy) - patient off treatment for < 1 week. 7. Inability to undergo a procedure under propofol sedation or General Anesthesia. 8. Female patients who are known to be pregnant. 9. Co-morbid conditions that place the subject at an unacceptable surgical risk (e.g., severe chronic obstructive pulmonary disease, hepatic failure, cardiac disease, autoimmune disorders or conditions of severe immunosuppression). 10. Any clinical evidence that the investigator feels would place the subject at increased risk with the deployment of the device. 11. Subject is participating in another study of a device, medication, biologic, or other agent within 90 days and could, in the opinion of the investigator, impact the results of this study. 12. Subject has other medical, social or psychological problems that in the opinion of the investigator would preclude them from receiving this treatment and the procedures and participating in evaluations pre- and post-treatment. |
Country | Name | City | State |
---|---|---|---|
France | Centre Hospitalier Universitaire (CHU) | Angers | |
France | Hopital Edouard Herriot | Lyon | |
France | Cochin University Hospital | Paris | |
Germany | Allgemeines Krankenhaus Celle | Celle | |
Germany | Clinic and Polyclinic for Interdisciplinary Endoscopy University Hospital Hamburg Eppendorf | Hamburg | |
Germany | Catholic Clinic Mainz | Mainz | |
Germany | Sana Klinikum Offenbach | Offenbach | |
Italy | Fondazione Poliambulanza Istituto Ospedaliero | Brescia | |
Italy | Università Cattolica del Sacro Cuore, Instituto di Clinica Chirurgica | Rome | |
Italy | Humanitas Research Hospital & Humanitas University | Rozzano | |
United States | Geisinger Medical Center | Danville | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Interscope, Inc. |
United States, France, Germany, Italy,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Primary Effectiveness Endpoint Defined as the Ability of the EndoRotor to Resect Lesions Without Concomitant Use of Other Resection Modalities and With no Device-related Serious Adverse Events Through the 90 Day Post Procedure Follow-up Visit. | Index Procedure through 90 Day Post Procedure Follow-up Visit | ||
Primary | Primary Safety Analysis Defined as the Occurrence of Serious Adverse Events Related to the EndoRotor Device as Measured From the Index Procedure Through the 90 Day Post Procedure Follow-up Visit. | Index Procedure through 90 Day Post Procedure Follow-up Visit | ||
Secondary | Efficacy Defined as the Number of Participants Where EndoRotor Was Able to Resect the Entire Lesion in a Single Procedure. | Index Procedure | ||
Secondary | Post-resection Stenosis Defined as the Occurrence of Colon Stenosis Following the Index Procedure. | 90-day follow-up visit | ||
Secondary | Rate of Disease Persistence Defined as Remnant Disease at the Location of the Index Resection as Determined Endoscopically by the Investigator at the 90 Day Follow-up Visit. | 90-day follow-up visit | ||
Secondary | Histologic Assessment Defined as the the Diagnostic Value of the Specimens Collected in the EndoRotor Specimen Trap (Could a Diagnosis be Rendered). | 90-day follow-up visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05178095 -
Artificial Intelligence in Colonic Polyp Detection
|
N/A | |
Completed |
NCT03179358 -
Clinical Trial Verifying C-REX LapAid and C-REX DMH/DMHC
|
N/A | |
Completed |
NCT04551014 -
Evaluation of EverLift in the Performance of Polypectomy for Polyps 4-9mm
|
N/A | |
Completed |
NCT04551001 -
Evaluation of Cold Forcep and Cold Snare Polypectomy for Polyps Less Than or Equal to 3mm in Size During Colonoscopy
|
N/A | |
Completed |
NCT04378660 -
Artificial Intelligence (AI) Validation Study for Polyp Detection
|
N/A | |
Completed |
NCT04442607 -
Clinical vAliDation of ARTificial Intelligence in POlyp Detection
|
N/A | |
Completed |
NCT05499546 -
Virtual Scale Function SCALE EYE: Variability and Systematic Differences
|
N/A | |
Completed |
NCT04195646 -
Computer Aided Detection of Polyps During Colonoscopy Procedures
|
N/A | |
Completed |
NCT04899700 -
Linked Color Imaging Versus White Light Endoscopy for the Evaluation of Scars of Non-pedunculated Polyps. LCI Scar Study.
|
N/A | |
Recruiting |
NCT04500392 -
High-flow Nasal Cannula Oxygenation Decrease Hypoxia in Sedated Gastrointestinal Endoscopes in Obesity
|
N/A | |
Recruiting |
NCT06447012 -
Artificial Intelligence Development for Colorectal Polyp Diagnosis
|
||
Completed |
NCT04357158 -
Breath Analysis as an Additional Test for Colorectal Cancer Screening to Reduce the Number of Unnecessary Colonoscopies
|
N/A | |
Completed |
NCT05389397 -
De-implementation of Outdated Colonoscopy Surveillance Interval Recommendations Among Patients With Low-risk Adenomas
|
N/A | |
Completed |
NCT04032912 -
The Non-Optical Resect and Discard Study (NORD)
|
||
Recruiting |
NCT05730192 -
EAGLE Trial CADDIE Artificial Intelligence Endoscopy
|
N/A | |
Completed |
NCT05829447 -
Combining Artificial Intelligence With Balloon Mucosal Exposure Device for Polyp Detection in Screening Individuals
|
N/A | |
Completed |
NCT04647266 -
Pronostic Score of Morbidity to Determine Risk of Complications After Endoscopic Submucosal Dissection for Colorectal Lesions
|
||
Not yet recruiting |
NCT06271941 -
Prophylactic Double Thermal Ablation After Endoscopic Mucosal Resection of Large Non-Pedunculated Colorectal Polyps
|
N/A | |
Recruiting |
NCT04117100 -
Advanced Endo-therapeutic Procedure : Registry-based Observational Study
|
||
Active, not recruiting |
NCT03089268 -
Molecular and Histological Characteristics of Serrated Lesions of the Colon
|